Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology; Engages Leading U.S. Investment Bank for NASDAQ Listing
"Our direct blood oxygenation system provides a solution for the high risks and costs associated with existing ventilation technology.
- "Our direct blood oxygenation system provides a solution for the high risks and costs associated with existing ventilation technology.
- The patent encompasses the technologies developed by Inspira, enabling the early treatment of patients with respiratory failure, who would otherwise be treated with invasive mechanical ventilation.
- Inspira Technologies is an innovative medical technology company in the respiratory support space.
- The Company has developed a breakthrough respiratory support system, the AXT, which directly oxygenates blood and immediately elevates and stabilizes patient oxygen levels.